MCQ Quiz: Buccal and Sublingual Drug Delivery

Buccal and sublingual (SL) drug delivery systems are designed for systemic absorption through the mucous membranes in the mouth. These routes allow for rapid onset, improved bioavailability, and avoidance of hepatic first-pass metabolism. This MCQ quiz covers drug properties suitable for buccal/SL delivery, formulation considerations, advantages, limitations, and clinical applications relevant to Pharm.D. students.

1. Which of the following routes bypasses the gastrointestinal tract and first-pass metabolism?

  • A. Oral tablet
  • B. Buccal
  • C. Enteric-coated tablet
  • D. Rectal
    Correct answer: B. Buccal

2. The sublingual route involves placing the drug:

  • A. Inside the cheek
  • B. Under the tongue
  • C. On the skin
  • D. In the stomach
    Correct answer: B. Under the tongue

3. Which of the following is an example of a drug administered sublingually?

  • A. Amoxicillin
  • B. Nitroglycerin
  • C. Ciprofloxacin
  • D. Omeprazole
    Correct answer: B. Nitroglycerin

4. The buccal route is typically used for:

  • A. Parenteral administration
  • B. Local action in the nasal cavity
  • C. Systemic drug delivery through cheek mucosa
  • D. Enteric-coated tablets
    Correct answer: C. Systemic drug delivery through cheek mucosa

5. Which of the following properties is essential for buccal/sublingual drugs?

  • A. Large molecular weight
  • B. Poor lipid solubility
  • C. Good permeability through mucosal tissue
  • D. Low potency
    Correct answer: C. Good permeability through mucosal tissue

6. Which of the following is a major advantage of sublingual administration?

  • A. Long onset time
  • B. Avoids hepatic first-pass metabolism
  • C. Requires large volume of fluid
  • D. Unstable in saliva
    Correct answer: B. Avoids hepatic first-pass metabolism

7. Buccal tablets are designed to:

  • A. Dissolve in the stomach
  • B. Disintegrate in the colon
  • C. Adhere to the inner cheek and release drug slowly
  • D. Dissolve rapidly under the tongue
    Correct answer: C. Adhere to the inner cheek and release drug slowly

8. Which of the following dosage forms is suitable for buccal administration?

  • A. Hard gelatin capsules
  • B. Chewable tablets
  • C. Mucoadhesive films
  • D. Rectal suppositories
    Correct answer: C. Mucoadhesive films

9. Drugs absorbed through the buccal mucosa enter:

  • A. Hepatic portal vein
  • B. Pulmonary circulation
  • C. Systemic circulation via the facial vein
  • D. Renal excretion pathway
    Correct answer: C. Systemic circulation via the facial vein

10. Sublingual administration is preferred when:

  • A. Slow release is desired
  • B. Rapid onset is needed
  • C. Drug has poor mucosal permeability
  • D. Drug is highly water-insoluble
    Correct answer: B. Rapid onset is needed

11. Which factor negatively affects sublingual absorption?

  • A. High vascularity
  • B. High salivary flow rate
  • C. Thin epithelium
  • D. Lipid solubility
    Correct answer: B. High salivary flow rate

12. A buccal patch delivers drugs by:

  • A. Immediate swallowing
  • B. Adhesion to the gingival tissue for prolonged release
  • C. Injection into cheek
  • D. Mixing with food
    Correct answer: B. Adhesion to the gingival tissue for prolonged release

13. What kind of drugs are best suited for buccal/sublingual delivery?

  • A. High-dose antibiotics
  • B. Poorly potent drugs
  • C. Lipophilic, low-dose drugs
  • D. Highly ionized compounds
    Correct answer: C. Lipophilic, low-dose drugs

14. Buccal dosage forms must avoid:

  • A. Prolonged contact
  • B. Mucoadhesive agents
  • C. Swallowing during drug release
  • D. Extended release
    Correct answer: C. Swallowing during drug release

15. Which excipient enhances adhesion in buccal formulations?

  • A. Magnesium stearate
  • B. Sodium lauryl sulfate
  • C. Carbopol
  • D. Talc
    Correct answer: C. Carbopol

16. The primary barrier for buccal drug absorption is the:

  • A. Stomach lining
  • B. Intestinal villi
  • C. Stratified squamous epithelium
  • D. Blood-brain barrier
    Correct answer: C. Stratified squamous epithelium

17. Sublingual tablets dissolve in:

  • A. Intestinal fluid
  • B. Gastric acid
  • C. Saliva
  • D. Plasma
    Correct answer: C. Saliva

18. The role of a mucoadhesive polymer is to:

  • A. Improve taste
  • B. Enhance drug solubility
  • C. Maintain contact between dosage form and mucosa
  • D. Increase saliva flow
    Correct answer: C. Maintain contact between dosage form and mucosa

19. Buccal drug delivery systems should have which feature?

  • A. High dosage
  • B. Rapid gastric transit
  • C. Controlled release with bioadhesion
  • D. Need for fluid intake
    Correct answer: C. Controlled release with bioadhesion

20. One clinical advantage of buccal tablets is:

  • A. Irregular dosing
  • B. Better taste than coated tablets
  • C. Reduced hepatic metabolism and patient-friendly application
  • D. Lower solubility
    Correct answer: C. Reduced hepatic metabolism and patient-friendly application

21. What is a drawback of sublingual delivery?

  • A. Delayed onset
  • B. Patient non-compliance due to holding dosage in mouth
  • C. Requires high-fat meals
  • D. No dosage control
    Correct answer: B. Patient non-compliance due to holding dosage in mouth

22. What feature improves permeability in buccal delivery?

  • A. Lower temperature
  • B. Surfactants or penetration enhancers
  • C. Enteric coating
  • D. Increased saliva
    Correct answer: B. Surfactants or penetration enhancers

23. Which drug is commonly used in buccal film form for pain management?

  • A. Metformin
  • B. Ondansetron
  • C. Fentanyl
  • D. Ciprofloxacin
    Correct answer: C. Fentanyl

24. Buccal absorption depends heavily on:

  • A. GI motility
  • B. Lipid solubility and pKa of the drug
  • C. Food intake
  • D. First-pass metabolism
    Correct answer: B. Lipid solubility and pKa of the drug

25. A mucoadhesive buccal patch may include which of the following?

  • A. Hydrophobic wax
  • B. Sugar syrup
  • C. Polyvinyl alcohol or Carbopol
  • D. Alcohol
    Correct answer: C. Polyvinyl alcohol or Carbopol

26. The ideal pH for sublingual absorption is:

  • A. <3
  • B. 5.5–7
  • C. >9
  • D. 2–3
    Correct answer: B. 5.5–7

27. Which layer of the oral mucosa offers least resistance to drug diffusion?

  • A. Buccal epithelium
  • B. Gingival epithelium
  • C. Sublingual mucosa
  • D. Palatal epithelium
    Correct answer: C. Sublingual mucosa

28. Bioavailability of SL/BU drugs is generally:

  • A. Lower than oral
  • B. Variable and erratic
  • C. Higher than oral due to bypassing liver metabolism
  • D. Same as IV
    Correct answer: C. Higher than oral due to bypassing liver metabolism

29. Buccal films are manufactured using:

  • A. Fluid-bed granulation
  • B. Solvent casting
  • C. Compression molding
  • D. Microwave drying
    Correct answer: B. Solvent casting

30. One limitation of buccal delivery is:

  • A. High cost of sugar
  • B. Low drug permeability for large molecules
  • C. Increased GI transit
  • D. Rapid metabolism
    Correct answer: B. Low drug permeability for large molecules

31. Sublingual administration offers which benefit over oral tablets?

  • A. Cost effectiveness
  • B. Slower absorption
  • C. Avoidance of degradation in GI tract
  • D. Longer duration
    Correct answer: C. Avoidance of degradation in GI tract

32. Buccal tablets should ideally have which shape?

  • A. Round and chewable
  • B. Oval and enteric-coated
  • C. Flat, mucoadhesive discs
  • D. Capsules
    Correct answer: C. Flat, mucoadhesive discs

33. Excessive salivation can:

  • A. Aid absorption
  • B. Wash drug away and reduce effectiveness
  • C. Increase mucoadhesion
  • D. Improve solubility
    Correct answer: B. Wash drug away and reduce effectiveness

34. A patient on buccal fentanyl should be advised to:

  • A. Swallow immediately
  • B. Remove after 5 minutes
  • C. Keep it in place until fully dissolved
  • D. Chew for faster effect
    Correct answer: C. Keep it in place until fully dissolved

35. Buccal administration is inappropriate when:

  • A. Rapid onset is needed
  • B. Drug causes mucosal irritation
  • C. Drug is low dose
  • D. Patient is unconscious
    Correct answer: B. Drug causes mucosal irritation

36. Saliva acts as a:

  • A. Flavor agent
  • B. Mucosal buffer and drug solvent
  • C. Drug transporter to stomach
  • D. Barrier to all drug absorption
    Correct answer: B. Mucosal buffer and drug solvent

37. One major factor influencing drug absorption from buccal tablets is:

  • A. Tablet color
  • B. Coating material
  • C. Contact time with mucosa
  • D. Patient height
    Correct answer: C. Contact time with mucosa

38. Buccal films provide drug release via:

  • A. Gastrointestinal route
  • B. Pulmonary route
  • C. Mucosal diffusion
  • D. Intravenous access
    Correct answer: C. Mucosal diffusion

39. What excipient helps increase residence time in buccal systems?

  • A. Water
  • B. Talc
  • C. HPMC or chitosan
  • D. Alcohol
    Correct answer: C. HPMC or chitosan

40. What is the typical onset of action for SL nitroglycerin?

  • A. 5–10 minutes
  • B. 30 minutes
  • C. 1–3 minutes
  • D. 1 hour
    Correct answer: C. 1–3 minutes

41. Buccal tablets should be stored:

  • A. In freezer
  • B. In open air
  • C. In dry, room-temperature containers
  • D. Under sunlight
    Correct answer: C. In dry, room-temperature containers

42. One reason for failure in buccal drug absorption is:

  • A. High lipid solubility
  • B. Small dose
  • C. High enzymatic activity in oral cavity
  • D. Low blood flow
    Correct answer: C. High enzymatic activity in oral cavity

43. Which form of nitroglycerin is ideal for SL use?

  • A. Patch
  • B. Tablet
  • C. Suspension
  • D. Injection
    Correct answer: B. Tablet

44. Buccal drug delivery is classified under:

  • A. Parenteral
  • B. Enteral
  • C. Mucosal systemic delivery
  • D. Inhalation
    Correct answer: C. Mucosal systemic delivery

45. Ultimately, buccal and SL systems are designed to:

  • A. Delay absorption
  • B. Improve patient discomfort
  • C. Provide rapid or controlled systemic absorption while avoiding GI and liver metabolism
  • D. Replace all injectables
    Correct answer: C. Provide rapid or controlled systemic absorption while avoiding GI and liver metabolism

46. Which of the following is an important counseling point for patients using SL tablets?

  • A. Swallow the tablet immediately
  • B. Store tablets in the refrigerator only
  • C. Do not eat or drink until the tablet is fully dissolved
  • D. Chew for faster onset
    Correct answer: C. Do not eat or drink until the tablet is fully dissolved

47. Buccal drug delivery is especially beneficial for:

  • A. Poorly potent antibiotics
  • B. Emergency medications requiring rapid action
  • C. Drugs that require gastric acid for activation
  • D. Hydrophilic peptides
    Correct answer: B. Emergency medications requiring rapid action

48. SL absorption primarily occurs through:

  • A. Active transport in the liver
  • B. Passive diffusion across oral mucosa
  • C. Filtration in the kidneys
  • D. Enzymatic digestion
    Correct answer: B. Passive diffusion across oral mucosa

49. Buccal tablets must be formulated to:

  • A. Completely resist saliva
  • B. Dissolve rapidly in the stomach
  • C. Stay in place and release drug slowly
  • D. Mask the tablet’s shape
    Correct answer: C. Stay in place and release drug slowly

50. The key formulation goal of SL tablets is to:

  • A. Increase pH
  • B. Increase hardness
  • C. Maximize rapid disintegration and absorption under the tongue
  • D. Reduce adhesion
    Correct answer: C. Maximize rapid disintegration and absorption under the tongue

Leave a Comment